I'm still struggling to accept the fiftyonecapital report's assumption of 90% success on the phase 2 trial. That's a fairly bold statement.
The phase 1 trials should have been somewhat expected as similar studies have been done before. Also, i didn't see any mention about any results so far relative to a placebo group.
In saying that ,I haven't spent a huge amount of time on this so i hope i'm wrong as we can continue to ride the wave. DYOR
I'm still struggling to accept the fiftyonecapital report's...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.050(15.4%) |
Mkt cap ! $82.30M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 38.0¢ | 34.0¢ | $1.052M | 2.938M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27068 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 42824 | 6 |
View Market Depth
| Last trade - 11.59am 25/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |
